Gene and cell therapy (GCT) has the potential to transform medicine, providing long term and potentially curative treatment options for a wide range of diseases. GenScript ProBio develops and manufactures plasmids of any size and for a wide range of application. Following the new drug development process, plasmids in different quality levels are provided to meet requirements in different stages with rapid turn-around time and 100% on-time delivery rate.
GenScript ProBio-Accelerating Vaccine Development against COVID-19
GenScript ProBio-Plasmid DNA Production for the Development of mRNA Therapy
LentiHelper™ Plasmid products are immediately available for packaging the 3rd generation lentiviral vector, to support pre-clinical and clinical phases’ needs.
Adopting most relevant GMP features, ProPlasmid™ fulfills your expectation in pre-IND phases and bring your projects through non-clinical stages cost-effectively.
GenScript ProBio provides our clients with GMPro™ plasmid under comprehensive quality assurance to meet your needs in early stage clinical. Get your project started now without waiting!
With accumulated experience in manufacturing plasmids as DS and DP, GenScript ProBio is fully equipped to produce GMP plasmid to meet the highest quality standards and regulatory compliance from April 2020!
Plasmid Process Development Center, Zhenjiang, CN
Our customer service representatives are available 24 hours a day, Monday through Friday, to assist you.